Announcement on Result of Shareholding Reduction by Shareholder
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
Shanghai Haohai Biological Technology Co., Ltd. has announced the results of a shareholder's reduction in holdings. The shareholder, Mr. Lou Guoliang, reduced his stake by selling a portion of his shares due to personal financial needs. The filing confirms compliance with relevant regulations regarding the share reduction process.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Haohai Biological Technology Co., Ltd. on 6ix
Earlier from Shanghai Haohai Biological Technology
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Notice on Convening the 2025 Annual General Meeting, the 1st Shareholders' Meeting of A Shares of 2026 and the 1st Shareholders' Meeting of H Shares of 2026
- Report for Q1 2026
- Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Multifocal Aspherical Intraocular Lens Product Obtaining the Medical Device Registration Certificate
- Announcement on Provision for Asset Impairment for 2025
Later from Shanghai Haohai Biological Technology
- Announcement on Notifying Creditors in Connection with the Repurchase of H-share Stocks
- Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
- Announcement on Voluntary Disclosure of the Holding Subsidiary’s Trifocal Intraocular Lens Product Obtaining the Medical Device Registration Certificate
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on the Cancellation of Repurchased H Shares
Follow Shanghai Haohai Biological Technology into a list and get an email when it puts out news.
Follow Shanghai Haohai Biological Technology